- Report
- October 2024
- 188 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- August 2024
- 138 Pages
Global
From €2858EUR$2,999USD£2,407GBP
- Report
- March 2025
- 739 Pages
Global
From €5194EUR$5,450USD£4,374GBP
- Report
- February 2025
- 214 Pages
Global
From €2383EUR$2,500USD£2,006GBP
- Report
- May 2024
- 180 Pages
Global
From €4289EUR$4,500USD£3,611GBP
- Report
- July 2024
- 100 Pages
Global
From €3574EUR$3,750USD£3,009GBP
- Report
- May 2024
- 237 Pages
Global
From €4241EUR$4,450USD£3,571GBP
- Report
- May 2024
- 200 Pages
Global
From €3955EUR$4,150USD£3,330GBP
- Report
- July 2024
- 119 Pages
Global
From €4432EUR$4,650USD£3,732GBP
- Report
- March 2025
- 192 Pages
Global
From €4717EUR$4,950USD£3,972GBP
- Report
- March 2025
- 185 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 181 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 186 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 196 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 186 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 191 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 191 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 187 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 186 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 198 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more